How the content of viral particles affects the outcome of herpesvirus infection? New paper with @ItsSonaliC @Weinberger_Lab@GoodrumVirusLab and more. A bitter-sweet moment as we remember of Cynthia, who passed away before this project's completion.
https://t.co/4WPVqQiFPk
Really delighted to share with the world our recent work 'Conversion of Escherichia coli to Generate All Biomass Carbon from CO2'. Great team effort with Roee Ben-Nissan, @yinonbaron and other current and former members of the Milo lab. https://t.co/sJyHsPaoxy
๐จNew Study๐จ Gladstone researchers collaborated with Xyphos Biosciences, Inc to develop a novel immunotherapy for #HIV.
@CellPressNews https://t.co/zuwR2j9voZ
Our Crohn's disease scRNA-seq paper is online! We report on a cellular module comprising of immune & stromal cells enriched in patients resistant to anti-TNF therapy.
With Jerome Martin @MiriamMerad@JudyCho7 and a fantastic team at @SinaiImmunol@SinaiGenetics@IcahnMountSinai
The Laplace transform is critical to hosting a sophisticated or "complex" function.
Laplace transform (v.): To hastily clean your home (usually by hiding things) before guests arrive.
our @PLOSBiology paper is out, we show how a #Robot, @YouTube and @Twitter can transform #STEM education and bridge geographical distances.
https://t.co/mzdTIMvb93
The Weinberger lab is always looking for talented and enthusiastic postdocs! Gladstone Institutes has a great working environment with outstanding benefits. Learn more here: https://t.co/9NZZUV8X1c
๐ฅ๐ฅ๐ฅNew preprint!!! Transcription factor duplicates (Msn2, Msn4) evolved to solve noise-control conflict in yeast. The study combines gene expression analysis, smFISH, fitness measurements and microscopy, led by Michal Chapal! read now:
https://t.co/uhag04hq0G
Super excited about this new preprint from @EduardoATorre using CRISPR screening to find modulators of rare-cell variability, with implications for therapy resistance in cancer! Tweetstorm from @EduardoATorre coming soon!
https://t.co/1UQET250kS
Our paper in Biorxiv demonstrating first oligonucleotide therapy that disrupts transcriptional feedback and mimics combination therapy to limit the emergence of antiviral resistance in Herpesviruses. #Biorxiv#Gladstoneinstitutes,#Herpesvirus,#antiviral
https://t.co/D2stNRVj9I
Please check out my lab's new paper https://t.co/H5eXUAqjC1
Fantastic data by Shawn Little and tour de force analysis/modeling by Ben Zoller: congrats, you guys rock!